Equitec Proprietary Markets, LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Equitec Proprietary Markets, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Oct 17, 2023	BUY	$98.98 - $115.74 $49.8 Million - $58.3 Million	503,500 Added 361.45%	642,800 $74.4 Million
Q2 2023 Jul 12, 2023	BUY	$96.34 - $112.38 $12.7 Million - $14.9 Million	132,300 Added 1890.0%	139,300 $14.3 Million
Q1 2023 Apr 28, 2023	BUY	$107.32 - $113.5 $429,280 - $454,000	4,000 Added 133.33%	7,000 $763,000
Q4 2022 Jan 31, 2023	BUY	$62.39 - $113.8 $187,170 - $341,400	3,000 New	3,000 $341,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.